Martin Bødtker Mortensen
@mabmortensen
Cardiologist and scientist with a special interest in preventive cardiology, atherosclerosis and imaging. Views are my own.
ID: 1213383613502242816
04-01-2020 08:56:20
302 Tweet
788 Followers
62 Following
#ICYMI: LDL, coronary plaque and risk for ASCVD Martin Bødtker Mortensen @JacobBentzon Ron Blankstein Michael J. Blaha Khurram Nasir @dzayeo Michael Maeng #AHAJournals
Excellent discussions on the use of imaging for personalized prevention! I agree with most points, but I consider biomarkers and imaging as complementary tools, not mutually exclusive. Lale Tokgozoglu Steve Nicholls academic.oup.com/eurheartj/arti…
I am standing for President-Elect of the European Atherosclerosis Society (EAS). Please vote before June 30! Link: eas-society.org/wp-login.php European Atherosclerosis Society
1/2 🧵 👉Another attempt to discuss the role of the LDLc in Atherosclerosis referring to “LDL-paradox” doi.org/10.1111/joim.1… ☝️Please, read the fantastic editorial by Borge G Nordestgaard et al, explaining the real reasons of the findings in the manuscript doi.org/10.1111/joim.1…
"Serial troponin-I and long-term outcomes in subjects with suspected acute coronary syndrome" finally out in #EJPC European Society of Cardiology Journals Link to full paper: academic.oup.com/eurjpc/advance… Muthu Vaduganathan Dr. Deepak L. Bhatt Tor Biering-Sørensen, MD, MSc, MPH, PhD @CIRL_DK Graphical abstract below:
Martin Bødtker Mortensen 2 critical points? #1 Are these results generalizable? Yes, seen same in MESA over long term period of 16+ years #2 Implications? #SeeDiseaseTreatDisease #NotAllLdlCreatedEqual
Hot of the press! jacc.org/doi/10.1016/j.… 🔥Very important paper >autoimmunity & athero: tour de force w/ CCTA and CAC severity/plaque burden led by Martin Bødtker Mortensen and others. Awareness is KEY & need for ongoing mechanistic work in #cardiorheum.